medigraphic.com
Órgano Oficial del Hospital Angeles Health System

2020, Number 4

<< Back Next >>

Acta Med 2020; 18 (4)

Anesthetic management in patient with peripartum cardiomyopathy

García BM, German CI, Athié GJM, Saucedo MEM

Language: Spanish
References: 25
Page: 395-398
PDF size: 161.27 Kb.


ABSTRACT

In order to describe the pathophysiology of peripartum cardiomyophaty -a low incidence disease- and the importance of anesthetic management, these patients underwent the following bibliography review. It was concluded that despite being a rare disease, it has high mortality in pregnant women who should be treated with low molecular weight heparin due to the incidence of teratogenicity with other anticoagulants, as well as the first line treatment needed. The anesthetic management is crucial to maintain an adequate preload and afterload, as well as the determination of the type of anesthesia that can be offered to the patient taking into account the laboratory studies to be able to choose regional techniques -which in these cases, is ideal- Being prepared to handle any complications and have the necessary adjuvants available to improve and maintain an adequate hemodynamic state.


REFERENCES

  1. Sliwa K, Hilfiker-Kleiner D, Petrie MC, Mebazaa A, Pieske B, Buchmann E, McMurray JJ. Current state of knowledge on aetiology, diagnosis, management, and therapy of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Working Group on peripartum cardiomyopathy. Eur J Heart Fail. 2010; 12 (8): 767-778.

  2. Johnson-Coyle L, Jensen L, Sobey A. Peripartum cardiomyopathy: review and practice guidelines. Am J Crit Care. 2012; 21 (2): 89-98.

  3. Tidswell M. Peripartum cardiomyopathy. Crit Care Clin. 2004; 20 (2): 777-788.

  4. Elkayam U, Goland S, Pieper PG, Silversides CK. High-risk cardiac disease in pregnancy. J Am Coll Cardiol. 2016; 68 (5): 502-516.

  5. Ware JS, Li J, Mazaika E, Yasso CM, DeSouza T, Cappola TP et al. Shared genetic predisposition in peripartum and dilated cardiomyopathies. NEJM. 2016; 374 (3): 233-241.

  6. Haghikia A, Podewski E, Libhaber E, Labidi S, Fischer D, Roentgen P et al. Phenotyping and outcome on contemporary management in a German cohort of patients with peripartum cardiomyopathy. Basic Res Cardiol. 2013; 108 (4): 366.

  7. Felker GM, Thompson RE, Hare JM, Hruban RH, Clemetson DE, Howard DL et al. Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy. NEJM. 2000; 342 (15): 1077-1084.

  8. Murali S, Baldisseri MR. Peripartum cardiomyopathy. Crit Care Med. 2005; 33 (10 Suppl): S340-346.

  9. Sliwa K, Forster O, Zhanje F, Candy G, Kachope J, Essop R. Outcome of subsequent pregnancy in patients with documented peripartum cardiomyopathy. Am J Cardiol. 2004; 93 (11): 1441-1443.

  10. Regitz-Zagrosek V, Roos-Hesselink JW, Bauersachs J, Blomström-Lundqvist C, Cífková R, De Bonis M, Nelson-Piercy C. ESC Guidelines for the management of cardiovascular diseases during pregnancy. Eur Heart J. 2018; 39 (34): 3165-3241.

  11. James AH, Jamison MG, Brancazio LR, Myers ER. Venous thromboembolism during pregnancy and the postpartum period: Incidence, risk factors, and mortality. Am J Obstet Gynecol. 2006; 194 (5): 1311-1315.

  12. Davis SM, Branch DW. Thromboprophylaxis in pregnancy: who and how? Obst Gynecol Clin N Am. 2010; 37 (2): 333-343.

  13. Hughes S. The obstetric patient with cardiac disease. In: Collins RE, Plaat F, Urguhart J. Textbook of obstetric Anaesthesia. London: Greenwich Medical Media. 2002, pp. 177-201.

  14. Martín J, Carvajal A, Arantzamendi M. Instrumentos para valorar al paciente con insuficiencia cardiaca avanzada: una revisión de la literatura. Anales Sis San Navarra. 2015; 38(3): 439-452.

  15. Soni B, Gautam PL, Grewal A, Kaur H. Anaesthetic management of two cases of peripartum cardiomyopathy. J Obstet Anaesth Crit Care. 2011; (1): 41-45.

  16. Patil V. Anaesthetic management in peripartum cardiomyopathy. J Anest & Inten Care Med. 2018; 6 (1): 1-4.

  17. Velickovic I, Leicht C. Continuous spinal anesthesia for cesarean section in a parturient with severe recurrent peripartum cardiomyopathy. Int J of Obstet Anesth. 2004; 13 (1): 40-43.

  18. Pryn A, Bryden F, Reeve W, Young S, Patrick A, McGrady E. Cardiomyopathy in pregnancy and caesarean section: Four case reports. Int J of Obstet Anesth. 2007; 16 (1): 68-73.

  19. Arendt, K, Lindley K. Obstetric anesthesia management of the patient with cardiac disease. Int J of Obstet Anesth. 2019; 37: 73-85.

  20. Ray P, Murphy G, Shutt L. Recognition and management of maternal cardiac disease in pregnancy. BJA. 2004; 93 (3): 428-439.

  21. Pyatt JR, Dubey G. Peripartum cardiomyopathy: current understanding, comprehensive management review and new developments. Postgrad Med J. 2010; 87 (1023): 34-39.

  22. Shnaider R, Ezri T, Szmuk P, Larson S, Warters RD, Katz J. Combined spinal-epidural anesthesia for Cesarean section in a patient with peripartum dilated cardiomyopathy. Can J Anesth/J Can Anesth. 2001; 48 (7): 681-683.

  23. Tiwari A, Agrawal J, Tayal S, Chadha M, Singla A, Valson G et al. Anesthetic management of peripartum cardiomyopathy using “epidural volume extension” technique: a case series. Ann Card Anaesth. 2012; 15 (1): 44.

  24. Castaño SJ, Castillo MJ, Escolano VF, Gallar GL, Montes PA, Samsó SE. Anestesia y analgesia obstétricas. Madrid: Ergon. 2007, pp. 125-134.

  25. Mebazaa A, Nieminen MS, Packer M, Cohen-Solal A, Kleber FX, Pocock SJ et al. Levosimendan vs dobutamine for patients with acute decompensated heart failure. JAMA. 2007; 297 (17): 1883-1891.




2020     |     www.medigraphic.com